Reducing Distress in Phase 1 Trial Caregivers: the P1-CaLL Study

This study seeks to decrease distress in the lives of the caregivers who are helping cancer patients who have entered a phase 1 clinical trial. The P1‐CaLL study uses a psychosocial intervention aimed at decreasing distress through the utilization of adaptive coping strategies (e.g., meditation, emotion‐focused coping) and cognitive behavioral techniques. Caregivers will receive 4 weeks of stress‐management sessions (over the phone). Then, they will be randomized to receive 4 more weekly sessions of either Cognitive Behavioral Therapy or Metta‐Meditation (over the phone). Participants will receive tasks to complete each week.